C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness

Heart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriure...

Full description

Bibliographic Details
Main Authors: Konstanze Michel, Melissa Herwig, Franziska Werner, Katarina Špiranec Spes, Marco Abeßer, Kai Schuh, Swati Dabral, Andreas Mügge, Hideo A. Baba, Boris V. Skryabin, Nazha Hamdani, Michaela Kuhn
Format: Article
Language:English
Published: American Society for Clinical investigation 2020-11-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.139910
id doaj-bc488a37aaa24a19ac2437a35f753e5f
record_format Article
spelling doaj-bc488a37aaa24a19ac2437a35f753e5f2021-08-02T20:49:32ZengAmerican Society for Clinical investigationJCI Insight2379-37082020-11-01522C-type natriuretic peptide moderates titin-based cardiomyocyte stiffnessKonstanze MichelMelissa HerwigFranziska WernerKatarina Špiranec SpesMarco AbeßerKai SchuhSwati DabralAndreas MüggeHideo A. BabaBoris V. SkryabinNazha HamdaniMichaela KuhnHeart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriuretic peptide (CNP), via its guanylyl cyclase-B (GC-B) receptor and cGMP/PKGI signaling, modulates titin-based ventricular compliance. To dissect GC-B–mediated effects of endogenous CNP in cardiomyocytes, we generated mice with cardiomyocyte-restricted GC-B deletion (CM GC-B–KO mice). The impact on heart morphology and function, myocyte passive tension, and titin isoform expression and phosphorylation was studied at baseline and after increased afterload induced by transverse aortic constriction (TAC). Pressure overload increased left ventricular endothelial CNP expression, with an early peak after 3 days. Concomitantly, titin phosphorylation at Ser4080, the site phosphorylated by PKGI, was augmented. Notably, in CM GC-B–KO mice this titin response was abolished. TAC-induced hypertrophy and fibrosis were not different between genotypes. However, the KO mice presented mild systolic and diastolic dysfunction together with myocyte stiffness, which were not observed in control littermates. In vitro, recombinant PKGI rescued reduced titin-Ser4080 phosphorylation and reverted passive stiffness of GC-B–deficient cardiomyocytes. CNP-induced activation of GC-B/cGMP/PKGI signaling in cardiomyocytes provides a protecting regulatory circuit preventing titin-based myocyte stiffening during early phases of pressure overload.https://doi.org/10.1172/jci.insight.139910Cardiology
collection DOAJ
language English
format Article
sources DOAJ
author Konstanze Michel
Melissa Herwig
Franziska Werner
Katarina Špiranec Spes
Marco Abeßer
Kai Schuh
Swati Dabral
Andreas Mügge
Hideo A. Baba
Boris V. Skryabin
Nazha Hamdani
Michaela Kuhn
spellingShingle Konstanze Michel
Melissa Herwig
Franziska Werner
Katarina Špiranec Spes
Marco Abeßer
Kai Schuh
Swati Dabral
Andreas Mügge
Hideo A. Baba
Boris V. Skryabin
Nazha Hamdani
Michaela Kuhn
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
JCI Insight
Cardiology
author_facet Konstanze Michel
Melissa Herwig
Franziska Werner
Katarina Špiranec Spes
Marco Abeßer
Kai Schuh
Swati Dabral
Andreas Mügge
Hideo A. Baba
Boris V. Skryabin
Nazha Hamdani
Michaela Kuhn
author_sort Konstanze Michel
title C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
title_short C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
title_full C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
title_fullStr C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
title_full_unstemmed C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
title_sort c-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
publisher American Society for Clinical investigation
series JCI Insight
issn 2379-3708
publishDate 2020-11-01
description Heart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriuretic peptide (CNP), via its guanylyl cyclase-B (GC-B) receptor and cGMP/PKGI signaling, modulates titin-based ventricular compliance. To dissect GC-B–mediated effects of endogenous CNP in cardiomyocytes, we generated mice with cardiomyocyte-restricted GC-B deletion (CM GC-B–KO mice). The impact on heart morphology and function, myocyte passive tension, and titin isoform expression and phosphorylation was studied at baseline and after increased afterload induced by transverse aortic constriction (TAC). Pressure overload increased left ventricular endothelial CNP expression, with an early peak after 3 days. Concomitantly, titin phosphorylation at Ser4080, the site phosphorylated by PKGI, was augmented. Notably, in CM GC-B–KO mice this titin response was abolished. TAC-induced hypertrophy and fibrosis were not different between genotypes. However, the KO mice presented mild systolic and diastolic dysfunction together with myocyte stiffness, which were not observed in control littermates. In vitro, recombinant PKGI rescued reduced titin-Ser4080 phosphorylation and reverted passive stiffness of GC-B–deficient cardiomyocytes. CNP-induced activation of GC-B/cGMP/PKGI signaling in cardiomyocytes provides a protecting regulatory circuit preventing titin-based myocyte stiffening during early phases of pressure overload.
topic Cardiology
url https://doi.org/10.1172/jci.insight.139910
work_keys_str_mv AT konstanzemichel ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT melissaherwig ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT franziskawerner ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT katarinaspiranecspes ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT marcoabeßer ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT kaischuh ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT swatidabral ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT andreasmugge ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT hideoababa ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT borisvskryabin ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT nazhahamdani ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
AT michaelakuhn ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness
_version_ 1721227094888808448